Myriad Genetics Inc (MYGN)
Operating return on assets (Operating ROA)
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -115,800 | -155,900 | -233,100 | -257,400 | -278,200 | -263,100 | -167,200 | -140,600 | -131,500 | -166,400 | -169,400 | -190,500 | -187,000 | -175,400 | -288,300 | -250,400 | -231,700 | -169,000 | -29,400 | -14,500 |
| Total assets | US$ in thousands | 1,081,300 | 1,085,100 | 1,110,500 | 1,146,500 | 1,149,100 | 1,187,200 | 1,169,300 | 1,198,700 | 1,212,000 | 1,210,200 | 1,255,400 | 1,320,700 | 1,335,900 | 1,360,300 | 1,336,900 | 1,444,500 | 1,404,600 | 1,446,700 | 1,578,300 | 1,591,200 |
| Operating ROA | -10.71% | -14.37% | -20.99% | -22.45% | -24.21% | -22.16% | -14.30% | -11.73% | -10.85% | -13.75% | -13.49% | -14.42% | -14.00% | -12.89% | -21.56% | -17.33% | -16.50% | -11.68% | -1.86% | -0.91% |
September 30, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $-115,800K ÷ $1,081,300K
= -10.71%
The operating return on assets (operating ROA) for Myriad Genetics Inc has shown a decreasing trend over the past few quarters, indicating a declining efficiency in generating operating profits from its assets. The negative values suggest that the company's operating income is insufficient to cover the asset base, leading to lower returns for shareholders.
The most recent data as of September 30, 2024, shows the company's operating ROA at -10.71%, a slight improvement from the previous quarter but still in negative territory. This indicates that the company continues to face challenges in effectively utilizing its assets to generate operating profits.
The company's operating ROA has fluctuated throughout the periods, with the highest value observed in March 2020 at -0.91% and the lowest at -24.21% in September 2023. The average operating ROA over the periods analyzed is -14.67%.
Overall, the consistent negative operating ROA figures suggest that Myriad Genetics Inc may be facing operational inefficiencies or challenges in its business model that are impacting its ability to generate profits from its asset base. Investors and stakeholders should closely monitor the company's efforts to improve its operational performance and asset utilization in order to enhance its financial sustainability and profitability.
Peer comparison
Sep 30, 2024